A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

NCT00077649 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: ribavirin [Copegus]
DRUG: ribavirin [Copegus]
DRUG: peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]
DRUG: peginterferon alfa-2a (PEG-IFN alfa-2a) [Pegasys]

Sponsor

Hoffmann-La Roche